Is Off-label repeat prescription of ketamine as a rapid antidepressant safe? Controversies, ethical concerns, and legal implications
10.1186/s12910-016-0087-3
Saved in:
Main Authors: | Zhang M.W., Harris K.M., Ho R.C. |
---|---|
Other Authors: | PSYCHOLOGICAL MEDICINE |
Format: | Review |
Published: |
BioMed Central Ltd.
2018
|
Online Access: | http://scholarbank.nus.edu.sg/handle/10635/143668 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
Ketamine Antidepressant : Breakthrough or Potential Hazard?
by: Tan, Teck Boon, et al.
Published: (2018) -
Controversies of the effect of ketamine on cognition
by: Zhang, M.W.B, et al.
Published: (2020) -
A STUDY OF DEPRESSION AND THE ANTIDEPRESSANT EFFECTS OF KETAMINE FROM AN IMMUNOINFLAMMATORY PERSPECTIVE
by: JOHNSON FAM
Published: (2020) -
Ethical Considerations for Clinical Research and Off-label Use of Ketamine to Treat Mood Disorders: The Balance between Risks and Benefits
by: Melvyn Zhang, et al.
Published: (2018) -
Prevalence and prescription of antidepressants in depression with somatic comorbidity in Asia: The research on east Asian psychotropic prescription patterns study
by: Chen C., et al.
Published: (2016)